These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 38512627)

  • 21. MRI features associated with HCC histologic subtypes: a western American and European bicenter study.
    Mulé S; Serhal A; Pregliasco AG; Nguyen J; Vendrami CL; Reizine E; Yang GY; Calderaro J; Amaddeo G; Luciani A; Miller FH
    Eur Radiol; 2023 Feb; 33(2):1342-1352. PubMed ID: 35999375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI.
    Liu X; Ni X; Li Y; Yang C; Wang Y; Ma C; Zhou C; Lu X
    Front Oncol; 2022; 12():934045. PubMed ID: 35847955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS.
    Cannella R; Dioguardi Burgio M; Beaufrère A; Trapani L; Paradis V; Hobeika C; Cauchy F; Bouattour M; Vilgrain V; Sartoris R; Ronot M
    JHEP Rep; 2021 Dec; 3(6):100380. PubMed ID: 34825155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological assessment of steatohepatitic hepatocellular carcinoma.
    Yamaoka K; Saitoh S; Kinowaki K; Fujiyama S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki F; Suzuki Y; Arase Y; Ikeda K; Fukusato T; Kumada H
    Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101799. PubMed ID: 34500120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steatotic and Steatohepatitic Hepatocellular Carcinomas: Features in a Series With Predominantly Viral Etiology.
    Aykutlu U; Argon A; Orman M; Ulukaya S; Zeytunlu M; Karasu Z; Günşar F; Nart D; Akarca U; Yilmaz F
    Am J Surg Pathol; 2021 Sep; 45(9):1252-1263. PubMed ID: 33826548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steatohepatitic hepatocellular carcinoma: imaging findings with clinicopathological correlation.
    Inui S; Kondo H; Tanahashi Y; Fukukura Y; Sano K; Morisaka H; Saito K; Kondo F; Fukusato T; Furui S; Oba H
    Clin Radiol; 2021 Feb; 76(2):160.e15-160.e25. PubMed ID: 33046228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy and precision of proton density fat fraction measurement across field strengths and scan intervals: A phantom and human study.
    Kim HJ; Cho HJ; Kim B; You MW; Lee JH; Huh J; Kim JK
    J Magn Reson Imaging; 2019 Jul; 50(1):305-314. PubMed ID: 30430684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
    Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
    Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological investigation of steatohepatitic hepatocellular carcinoma: A multicenter study using immunohistochemical analysis of adenoma-related markers.
    Taniai M; Hashimoto E; Tobari M; Kodama K; Tokushige K; Yamamoto M; Takayama T; Sugitani M; Sano K; Kondo F; Fukusato T
    Hepatol Res; 2018 Nov; 48(12):947-955. PubMed ID: 30058778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity.
    Fujiwara N; Nakagawa H; Enooku K; Kudo Y; Hayata Y; Nakatsuka T; Tanaka Y; Tateishi R; Hikiba Y; Misumi K; Tanaka M; Hayashi A; Shibahara J; Fukayama M; Arita J; Hasegawa K; Hirschfield H; Hoshida Y; Hirata Y; Otsuka M; Tateishi K; Koike K
    Gut; 2018 Aug; 67(8):1493-1504. PubMed ID: 29437870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.
    Ziol M; Poté N; Amaddeo G; Laurent A; Nault JC; Oberti F; Costentin C; Michalak S; Bouattour M; Francoz C; Pageaux GP; Ramos J; Decaens T; Luciani A; Guiu B; Vilgrain V; Aubé C; Derman J; Charpy C; Zucman-Rossi J; Barget N; Seror O; Ganne-Carrié N; Paradis V; Calderaro J
    Hepatology; 2018 Jul; 68(1):103-112. PubMed ID: 29281854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI.
    Kim YY; An C; Kim S; Kim MJ
    Eur Radiol; 2018 May; 28(5):2038-2046. PubMed ID: 29230525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
    Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
    J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma.
    Lee JS; Yoo JE; Kim H; Rhee H; Koh MJ; Nahm JH; Choi JS; Lee KH; Park YN
    PLoS One; 2017; 12(3):e0171922. PubMed ID: 28273155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular Carcinoma: Histologic Subtypes.
    Shafizadeh N; Kakar S
    Surg Pathol Clin; 2013 Jun; 6(2):367-84. PubMed ID: 26838979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study.
    Ando S; Shibahara J; Hayashi A; Fukayama M
    Virchows Arch; 2015 Nov; 467(5):535-42. PubMed ID: 26311355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease.
    Idilman IS; Tuzun A; Savas B; Elhan AH; Celik A; Idilman R; Karcaaltincaba M
    Abdom Imaging; 2015 Aug; 40(6):1512-9. PubMed ID: 25715922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients.
    Shibahara J; Ando S; Sakamoto Y; Kokudo N; Fukayama M
    Histopathology; 2014 Jun; 64(7):951-62. PubMed ID: 24898917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance fat quantification in living donor liver transplantation.
    Chiang HJ; Lin LH; Li CW; Lin CC; Chiang HW; Huang TL; Chen CL; Cheng YF
    Transplant Proc; 2014 Apr; 46(3):666-8. PubMed ID: 24767318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India.
    Jain D; Nayak NC; Kumaran V; Saigal S
    Arch Pathol Lab Med; 2013 Jul; 137(7):961-6. PubMed ID: 23808468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.